electroCore to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum
November 07 2023 - 8:00AM
electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic
medicine and wellness company, announced today that Company CEO,
Dan Goldberger, is scheduled to attend the Canaccord Genuity
MedTech, Diagnostics and Digital Health & Services Forum taking
place at the Westin NY Grand Central on November 16, 2023.
1x1 Meetings
electroCore will host 1x1 investor meetings on November 16,
2023. Please contact your Canaccord representative to schedule a
1x1 meeting.
About electroCore, Inc.electroCore, Inc. is a
commercial stage bioelectronic medicine and wellness company
dedicated to improving health through its non-invasive vagus nerve
stimulation (“nVNS”) technology platform. Our focus is the
commercialization of medical devices for the management and
treatment of certain medical conditions and consumer product
offerings utilizing nVNS to promote general wellbeing and human
performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.
Contact:ECOR Investor Relations(973)
302-9253investors@electrocore.com
electroCore (NASDAQ:ECOR)
Historical Stock Chart
From Apr 2024 to May 2024
electroCore (NASDAQ:ECOR)
Historical Stock Chart
From May 2023 to May 2024